Cumulus Oncology: Funding, Investors & Team (Oct 2026)
Cumulus Oncology focuses on creating cancer treatments for medical settings where there is a significant lack of options. Our aim is to enhance the effectiveness and results of existing and experimental therapies by targeting important biological pathways. With the support of a prosperous oncology entrepreneur and a team of experienced professionals and industry partners in drug discovery and development, we bring an abundance of knowledge and valuable perspectives to improve the outcomes for cancer patients.
Cumulus Oncology has raised $17.0M across 2 funding rounds on record, the most recent a Seed of $11.4M announced in Jan 2024.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cumulus Oncology Company Profile and Key Stats
Latest funding round on record: Jan 2024.
Cumulus Oncology Funding Rounds
Cumulus Oncology raised $5.6M in an undisclosed round announced in Feb 2022.
1.9 years later, a Seed of $11.4M was announced in Jan 2024.
Cumulus Oncology Founders and Leadership Team
Contact details for the Cumulus Oncology team: 1 of 1 has an email address on file.
Start 14-day free trial →Cumulus Oncology Funding Compared to Other Biotechnology Startups
Cumulus Oncology's latest round of $11.4M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cumulus Oncology in Biotechnology and Edinburgh
Companies Similar to Cumulus Oncology
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
Cumulus Oncology Funding FAQs
What does Cumulus Oncology do?
Cumulus Oncology focuses on creating cancer treatments for medical settings where there is a significant lack of options. Our aim is to enhance the effectiveness and results of existing and experimental therapies by targeting important biological pathways. With the support of a prosperous oncology entrepreneur and a team of experienced professionals and industry partners in drug discovery and development, we bring an abundance of knowledge and valuable perspectives to improve the outcomes for cancer patients.
How much funding has Cumulus Oncology raised?
Cumulus Oncology has raised $17.0M across 2 rounds on record. The most recent is a Seed of $11.4M announced in Jan 2024.
When did Cumulus Oncology last raise funding?
Cumulus Oncology's most recent funding round on record is a Seed of $11.4M, announced in Jan 2024.
Who founded Cumulus Oncology?
FundedIQ lists Clare Wareing (Founder) at Cumulus Oncology.
Where is Cumulus Oncology headquartered?
Cumulus Oncology is based in Edinburgh, United Kingdom.
How many employees does Cumulus Oncology have?
Cumulus Oncology is in the 11-50 employee band.
How does Cumulus Oncology's funding compare to other Biotechnology startups?
Cumulus Oncology's latest round of $11.4M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Cumulus Oncology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cumulus Oncology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.